Literature DB >> 18708755

c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster.

Elaine Y Chung1, Michael Dews, Diana Cozma, Duonan Yu, Erik A Wentzel, Tsung-Cheng Chang, Janell M Schelter, Michele A Cleary, Joshua T Mendell, Andrei Thomas-Tikhonenko.   

Abstract

The dleu2 tumor suppressor locus encodes two microRNAs, miR-15a and miR-16, which are thought to play an important role in B-cell neoplasms. However, relatively little is known about proteins that regulate or are regulated by this microRNA cluster. Here we demonstrate that the Pax5 oncoprotein downregulates the dleu2 gene and at the same time boosts expression of its own heterodimeric partner c-Myb. Interestingly, c-Myb upregulation occurs primarily at a post-transcriptional level, suggesting that it might be a target for microRNAs such as miR-15a/16. Indeed, miR-15a/16 have predicted binding sites in the c-Myb 3'-UTR and through them diminish protein output in luciferase sensor assays. Moreover, forced overexpression of miR-15a/16 reduces endogenous c-Myb levels and compromises Pax5 function. Conversely, restoration of c-Myb levels partly alleviates tumors suppressive effects of miR-15a/16, suggesting that c-Myb is a key downstream target of this microRNA cluster.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18708755      PMCID: PMC2783585          DOI: 10.4161/cbt.7.11.6722

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  31 in total

1.  Expression profiling reveals off-target gene regulation by RNAi.

Authors:  Aimee L Jackson; Steven R Bartz; Janell Schelter; Sumire V Kobayashi; Julja Burchard; Mao Mao; Bin Li; Guy Cavet; Peter S Linsley
Journal:  Nat Biotechnol       Date:  2003-05-18       Impact factor: 54.908

2.  Myb and Ets proteins cooperate in transcriptional activation of the mim-1 promoter.

Authors:  H Dudek; R V Tantravahi; V N Rao; E S Reddy; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

3.  Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.

Authors:  Duonan Yu; David Allman; Michael H Goldschmidt; Michael L Atchison; John G Monroe; Andrei Thomas-Tikhonenko
Journal:  Blood       Date:  2002-10-24       Impact factor: 22.113

4.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

5.  Cooperative binding of c-Myb and Pax-5 activates the RAG-2 promoter in immature B cells.

Authors:  Hiroyuki Kishi; Zhe-Xiong Jin; Xing-Cheng Wei; Takuya Nagata; Tadashi Matsuda; Shigeru Saito; Atsushi Muraguchi
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

6.  Lymphoid enhancer-binding factor-1 binds and activates the recombination-activating gene-2 promoter together with c-Myb and Pax-5 in immature B cells.

Authors:  Zhe-Xiong Jin; Hiroyuki Kishi; Xing-Cheng Wei; Tadashi Matsuda; Shigeru Saito; Atsushi Muraguchi
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

7.  The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells.

Authors:  Huiwu Zhao; Anna Kalota; Shenghao Jin; Alan M Gewirtz
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

8.  Organization and reorganization of immunoglobulin genes in A-MULV-transformed cells: rearrangement of heavy but not light chain genes.

Authors:  F Alt; N Rosenberg; S Lewis; E Thomas; D Baltimore
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

9.  Tripartite structure of the avian erythroblastosis virus E26 transforming gene.

Authors:  M F Nunn; P H Seeburg; C Moscovici; P H Duesberg
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

10.  Human MicroRNA targets.

Authors:  Bino John; Anton J Enright; Alexei Aravin; Thomas Tuschl; Chris Sander; Debora S Marks
Journal:  PLoS Biol       Date:  2004-10-05       Impact factor: 8.029

View more
  28 in total

Review 1.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

Review 2.  New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer.

Authors:  Göran Stenman; Mattias K Andersson; Ywonne Andrén
Journal:  Cell Cycle       Date:  2010-08-28       Impact factor: 4.534

3.  MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas.

Authors:  Ruth G Tatevossian; Bo Tang; James Dalton; Tim Forshew; Andrew R Lawson; Jing Ma; Geoff Neale; Sheila A Shurtleff; Simon Bailey; Amar Gajjar; Suzanne J Baker; Denise Sheer; David W Ellison
Journal:  Acta Neuropathol       Date:  2010-11-03       Impact factor: 17.088

4.  Micro RNA responses to chronic or acute exposures to low dose ionizing radiation.

Authors:  M Ahmad Chaudhry; Romaica A Omaruddin; Bridget Kreger; Sonia M de Toledo; Edouard I Azzam
Journal:  Mol Biol Rep       Date:  2012-02-25       Impact factor: 2.316

5.  Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.

Authors:  Annika K Wefers; Damian Stichel; Daniel Schrimpf; Roland Coras; Mélanie Pages; Arnault Tauziède-Espariat; Pascale Varlet; Daniel Schwarz; Figen Söylemezoglu; Ute Pohl; José Pimentel; Jochen Meyer; Ekkehard Hewer; Anna Japp; Abhijit Joshi; David E Reuss; Annekathrin Reinhardt; Philipp Sievers; M Belén Casalini; Azadeh Ebrahimi; Kristin Huang; Christian Koelsche; Hu Liang Low; Olinda Rebelo; Dina Marnoto; Albert J Becker; Ori Staszewski; Michel Mittelbronn; Martin Hasselblatt; Jens Schittenhelm; Edmund Cheesman; Ricardo Santos de Oliveira; Rosane Gomes P Queiroz; Elvis Terci Valera; Volkmar H Hans; Andrey Korshunov; Adriana Olar; Keith L Ligon; Stefan M Pfister; Zane Jaunmuktane; Sebastian Brandner; Ruth G Tatevossian; David W Ellison; Thomas S Jacques; Mrinalini Honavar; Eleonora Aronica; Maria Thom; Felix Sahm; Andreas von Deimling; David T W Jones; Ingmar Blumcke; David Capper
Journal:  Acta Neuropathol       Date:  2019-09-28       Impact factor: 17.088

6.  MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13.

Authors:  Vijay G Sankaran; Tobias F Menne; Danilo Šćepanović; Jo-Anne Vergilio; Peng Ji; Jinkuk Kim; Prathapan Thiru; Stuart H Orkin; Eric S Lander; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-04       Impact factor: 11.205

7.  The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma.

Authors:  Brittany C Parker; Matti J Annala; David E Cogdell; Kirsi J Granberg; Yan Sun; Ping Ji; Xia Li; Joy Gumin; Hong Zheng; Limei Hu; Olli Yli-Harja; Hannu Haapasalo; Tapio Visakorpi; Xiuping Liu; Chang-Gong Liu; Raymond Sawaya; Gregory N Fuller; Kexin Chen; Frederick F Lang; Matti Nykter; Wei Zhang
Journal:  J Clin Invest       Date:  2013-01-09       Impact factor: 14.808

8.  MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia.

Authors:  E Mets; J Van der Meulen; G Van Peer; M Boice; P Mestdagh; I Van de Walle; T Lammens; S Goossens; B De Moerloose; Y Benoit; N Van Roy; E Clappier; B Poppe; J Vandesompele; H-G Wendel; T Taghon; P Rondou; J Soulier; P Van Vlierberghe; F Speleman
Journal:  Leukemia       Date:  2014-09-18       Impact factor: 11.528

9.  Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas.

Authors:  Olesya Chayka; Daisy Corvetta; Michael Dews; Alessandro E Caccamo; Izabela Piotrowska; Giorgia Santilli; Sian Gibson; Neil J Sebire; Nourredine Himoudi; Michael D Hogarty; John Anderson; Saverio Bettuzzi; Andrei Thomas-Tikhonenko; Arturo Sala
Journal:  J Natl Cancer Inst       Date:  2009-04-28       Impact factor: 13.506

10.  Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.

Authors:  Marta Persson; Ywonne Andrén; Joachim Mark; Hugo M Horlings; Fredrik Persson; Göran Stenman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.